08.04.25 -- Advanced Manufacturing And CDMOs Are Rewriting The CGT Cost Equation

Discover how one family's race against time led to the creation of a groundbreaking gene therapy for their daughter, just 14 months after her ultra-rare disease diagnosis.

Discover how high-speed isolator lines enable sterile, scalable manufacturing for complex biologics and injectables with unmatched efficiency and product integrity.

Observe as experts highlight innovative tools and strategies advancing the safety of gene editing therapies while addressing off-target effects, regulatory demands, and manufacturing efficiency.

Discover how this Peripheral Blood Mononuclear Cell (PBMC) isolation method can transform CAR-T manufacturing by reducing costs, accelerating timelines, and improving patient accessibility.

Dive into the scope of <382> for pharmaceutical closures and the regulatory landscape. Learn about new required tests and instrumentation for compliance and recommendations on method implementation.

Explore how a rodent nose-only AAV inhalation model can optimize the safe and effective delivery of aerosolized gene therapies for monogenic pulmonary diseases.

Can AI predict immunotherapy success earlier than traditional methods? Experts reveal data-backed applications in this enlightening session.

Gain valuable insights into the critical role of apheresis in sourcing high-quality cellular material for therapies.

View the webinar and learn how efficient project management and optimized communication are cornerstones of a successful transfer process.

Uncover why leveraging strong scientific expertise and comprehensive testing techniques will be vital in expediting development and upholding the integrity of these life-saving treatments.